ELOS B のPE 比率は同業他社と比較してどうか。

ELOS Bは、同業他社の平均 ( { 104.3 x) と比較したPrice-To-Earnings比率 ( 41.9 x) に基づいて高価です。

ELOS B'のPE レシオは、European Medical Equipment 業界の他社と比較してどうか。

ELOS Bは、 Swedish Medical Equipment業界平均 (27.1x) (104.3 x) と比較すると、 Price-To-Earnings比率 ( 27.1 x) に基づくと高価です。

ELOS B'のPE レシオとフェアPE レシオを比較すると？これは、会社の予想利益成長率、利益率、その他のリスク要因を考慮した予想PE レシオです。

評価分析のためのELOS BのPrice-To-Earnings公正比率を計算するにはデータが不十分です。

ELOS B 、その将来キャッシュフローを見たときの公正価格はいくらになるだろうか？この見積もりには、割引キャッシュフローモデルを使用します。

ELOS B ( SEK203 ) は、当社の [[公正価値]] の見積もり ( SEK21.73 ) を上回って取引されています。

アナリストの12ヶ月の予想と、コンセンサス目標株価に対する統計的信頼性は？

価格予測を表示するにはデータが不十分です。

Elos Medtech ( ) - 株価, ニュースと分析OM:ELOS B

ELOS B 株式概要

Elos Medtech AB (publ) engages in the development and contract manufacturing of medical devices and components for dental, orthopedics, diagnostics, and hearing and other medical device markets. 詳細

ELOS B ファンダメンタル分析
スノーフレーク・スコア
評価	0/6
将来の成長	0/6
過去の実績	2/6
財務の健全性	6/6
配当金	0/6

リスク分析

過去1年間で株主の希薄化は大幅に進んだ

利益率(5.4%)は昨年より低い(11.2%)

Elos Medtech AB (publ) 競合他社

Surgical Science Sweden

OM:SUS

SEK 7.5b

CellaVision

OM:CEVI

SEK 5.2b

Arjo

OM:ARJO B

SEK 9.0b

Stille

OM:STIL

SEK 1.8b

価格と性能

の歴代最高値、変動、値下がりまとめElos Medtech
過去の株価
現在の株価	SEK 203.00
52週高値	SEK 295.00
52週安値	SEK 185.00
ベータ	1.12
11ヶ月の変化	-5.14%
3ヶ月変化	-8.14%
1年変化	-17.31%
33年間の変化	96.14%
5年間の変化	195.92%
IPOからの変化	1,253.33%

Recent updates

The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares

Feb 28

Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?

Feb 24

Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment

Feb 11

When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?

Jan 31

How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?

Jan 18

Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture

Jan 06

Could The Elos Medtech AB (publ) (STO:ELOS B) Ownership Structure Tell Us Something Useful?

Dec 26

Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet

Dec 13

Here's Why We Don't Think Elos Medtech's (STO:ELOS B) Statutory Earnings Reflect Its Underlying Earnings Potential

Nov 30

Elos Medtech AB (publ)'s (STO:ELOS B) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Nov 17

株主還元

	ELOS B	SE Medical Equipment	SE 市場
7D	0.5%	-2.2%	0.1%
1Y	-17.3%	-6.0%	11.8%

業界別リターン: ELOS B過去 1 年間で-6 % の収益を上げたSwedish Medical Equipment業界を下回りました。

リターン対市場: ELOS Bは、過去 1 年間で11.8 % のリターンを上げたSwedish市場を下回りました。

価格変動

Is ELOS B's price volatile compared to industry and market?
ELOS B volatility
ELOS B Average Weekly Movement	3.7%
Medical Equipment Industry Average Movement	7.5%
Market Average Movement	5.5%
10% most volatile stocks in SE Market	11.2%
10% least volatile stocks in SE Market	3.3%

安定した株価: ELOS B過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: ELOS Bの週次ボラティリティ ( 4% ) は過去 1 年間安定しています。

会社概要

設立	従業員	CEO（最高経営責任者	ウェブサイト
1923	653	Stefano Alfonsi	elosmedtech.com

Elos Medtech AB (publ) 基礎のまとめ

Elos Medtech の収益と売上を時価総額と比較するとどうか。
ELOS B 基礎統計学
時価総額	SEK 5.73b
収益（TTM）	SEK 54.95m
売上高(TTM)	SEK 1.02b

104.3x

PER（株価収益率

5.6x

P/Sレシオ

ELOS B は割高か？

公正価値と評価分析を参照

収益と収入

最新の決算報告書（TTM）に基づく主な収益性統計
ELOS B 損益計算書（TTM）
収益	SEK 1.02b
売上原価	SEK 676.62m
売上総利益	SEK 341.02m
その他の費用	SEK 286.07m
収益	SEK 54.95m

直近の収益報告

Sep 30, 2023

次回決算日

Feb 29, 2024

一株当たり利益（EPS）	1.95
グロス・マージン	33.51%
純利益率	5.40%
有利子負債／自己資本比率	51.6%

ELOS B の長期的なパフォーマンスは？

過去の実績と比較を見る

配当金

0.5%

現在の配当利回り

15%

配当性向

ELOS B 株式概要

リスク分析

Elos Medtech AB (publ) 競合他社

OM:SUS

SEK 7.5b

OM:CEVI

SEK 5.2b

OM:ARJO B

SEK 9.0b

OM:STIL

SEK 1.8b

価格と性能

最新ニュース

Elos Medtech AB (publ) (OM:ELOS B) acquired Klingel Holding GmbH from IK Partners and Management.

Nasdaq Stockholm Approves Elos Medtech's Application for De-Listing

Elos Medtech Applies for De-Listing from Nasdaq Stockholm

New major risk - Shareholder dilution

Elos Medtech AB (publ) to Report Fiscal Year 2024 Results on Feb 28, 2025

Third quarter 2023 earnings released

Recent updates

Elos Medtech AB (publ) (OM:ELOS B) acquired Klingel Holding GmbH from IK Partners and Management.

Nasdaq Stockholm Approves Elos Medtech's Application for De-Listing

Elos Medtech Applies for De-Listing from Nasdaq Stockholm

New major risk - Shareholder dilution

Elos Medtech AB (publ) to Report Fiscal Year 2024 Results on Feb 28, 2025

Third quarter 2023 earnings released

Elos Medtech AB (publ) (OM:ELOS B) entered an agreement to acquire KLINGEL medical metal GmbH from IK Partners and Management for an enterprise value of €370 million.

New minor risk - Profit margin trend

Second quarter 2023 earnings released

Investor sentiment improves as stock rises 20%

Elos Medtech AB (Publ) Elects Winfried Schaller as Board Member

First quarter 2023 earnings released

Investor sentiment improves as stock rises 16%

Full year 2022 earnings released: EPS: kr9.31 (vs kr9.37 in FY 2021)

No independent directors

Elos Medtech AB (publ) to Report Q3, 2023 Results on Oct 19, 2023

Third quarter 2022 earnings released

Elos Medtech AB Announces Nomination Committee Appointments

Elos Medtech AB (Publ) Announces Management Changes

Elos Medtech AB (Publ) Announces Management Changes

Second quarter 2022 earnings released

Elos Medtech AB (publ) Omits Dividend for the Year 2021

First quarter 2022 earnings: Revenues miss analyst expectations

Less than half of directors are independent

Elos Medtech AB (publ)(OM:ELOS B) dropped from OMX Nordic Small Cap Index

Chief Financial Officer recently sold kr159k worth of stock

Chief Financial Officer recently sold kr159k worth of stock

Investor sentiment improved over the past week

Third quarter 2021 earnings released

Investor sentiment deteriorated over the past week

Calculating The Fair Value Of Elos Medtech AB (publ) (STO:ELOS B)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Independent Director recently sold kr848k worth of stock

Second quarter 2021 earnings released: EPS kr2.28 (vs kr0.85 in 2Q 2020)

TA Associates Management, L.P. through its funds Ta Xiii-B, L.P., Ta Xiii-A, L.P. and TA Investors XIII, L.P. made an offer to acquire Elos Medtech AB (publ) (OM:ELOS B) from a group of sellers for SEK 1.7 billion.

Elos Medtech in Talks of Possible Takeover Bid

Is Now The Time To Look At Buying Elos Medtech AB (publ) (STO:ELOS B)?

Here's Why I Think Elos Medtech (STO:ELOS B) Is An Interesting Stock

First quarter 2021 earnings released

Upcoming dividend of kr1.50 per share

Returns On Capital Are Showing Encouraging Signs At Elos Medtech (STO:ELOS B)

We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt

President & CEO recently sold kr801k worth of stock

Should Elos Medtech AB (publ) (STO:ELOS B) Be Part Of Your Dividend Portfolio?

New 90-day high: kr121

The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares

President & CEO recently bought kr233k worth of stock

Revenue and earnings miss expectations

Full year 2020 earnings released: EPS kr4.46 (vs kr4.77 in FY 2019)

Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?

Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment

New 90-day high: kr117

When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?

How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?

Elos Medtech AB (publ) Announces Executive Changes

Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture

New 90-day high: kr109